These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 5700750)
1. [Multiple sclerosis: therapeutic attempt using Menadion (vitamin K3)]. Henzi H; Uehlinger A Schweiz Med Wochenschr; 1968 May; 98(18):688-91. PubMed ID: 5700750 [No Abstract] [Full Text] [Related]
2. [Emetine in the management of multiple sclerosis]. Lenský P Z Arztl Fortbild (Jena); 1968 Mar; 62(6):322-6. PubMed ID: 5714932 [No Abstract] [Full Text] [Related]
3. Intrathecal methylprednisolone for multiple sclerosis: evaluation by a standard neurological rating. Baker AG Ann Allergy; 1967 Dec; 25(12):665-72. PubMed ID: 6072742 [No Abstract] [Full Text] [Related]
4. [Clinical note apropos of 2 recent cases of multiple sclerosis with paroxysmal motor manifestations]. Vallat JN; Gaudin H; Tapie P; Vallat I Bord Med; 1972 Sep; 5(13):1565-8. PubMed ID: 4636176 [No Abstract] [Full Text] [Related]
6. [Therapeutic efficacy during active phases of multiple sclerosis: gait analysis and comparison with the EDSS score]. Fauchard-Renard C; Renard JF; Miret N; Hannequin D; Mihout B; Weber J Rev Neurol (Paris); 2001 Jul; 157(6-7):649-54. PubMed ID: 11458184 [TBL] [Abstract][Full Text] [Related]
7. An investigation of physical and intellectual changes in multiple sclerosis. Fink SL; Houser HB Arch Phys Med Rehabil; 1966 Feb; 47(2):56-61. PubMed ID: 5910077 [No Abstract] [Full Text] [Related]
8. [Cyclophosphamide in therapy of chronic progressive multiple sclerosis. Critical analysis of current studies]. Pette M; Hartung HP; Toyka KV Nervenarzt; 1994 Apr; 65(4):271-4. PubMed ID: 8015636 [No Abstract] [Full Text] [Related]
9. A discussion concerning physical trauma in multiple sclerosis. Namerow NS Bull Los Angeles Neurol Soc; 1967 Apr; 32(2):117-24. PubMed ID: 6033817 [No Abstract] [Full Text] [Related]
10. [Comparative evaluation of methods of treating multiple sclerosis]. Briskman AN Vrach Delo; 1966 Sep; 9():147-8. PubMed ID: 4175862 [No Abstract] [Full Text] [Related]
11. The management of multiple sclerosis. II. Serial neurologic examinations and use of corticotropin and glucocorticoids. McFarland HR Mo Med; 1969 Feb; 66(2):113-6. PubMed ID: 4302927 [No Abstract] [Full Text] [Related]
12. The diagnosis of multiple sclerosis. Flora GC Minn Med; 1967 Mar; 50(3):395-6. PubMed ID: 6039857 [No Abstract] [Full Text] [Related]
13. [2 cases of uveitis in multiple sclerosis type encephalitis]. Le Rebeller M Bull Soc Ophtalmol Fr; 1971 Mar; 71(3):331-4. PubMed ID: 5139462 [No Abstract] [Full Text] [Related]
14. [B.A.L. in the clinico-therapeutic experience of multiple sclerosis. (Some results)]. Nardini L Riv Sper Freniatr Med Leg Alien Ment; 1966 Apr; 90(2):472-86. PubMed ID: 5919440 [No Abstract] [Full Text] [Related]
15. [Disorders of objective sensitivity in multiple sclerosis]. Marforio S G Psichiatr Neuropatol; 1968; 96(4):779-95. PubMed ID: 5738036 [No Abstract] [Full Text] [Related]
16. [Hereditary resistance to vitamin K antagonists. Apropos of a case]. Paganelli F; Conard J; Gelisse R; Ricard P; Samama M; Lévy S Arch Mal Coeur Vaiss; 1999 Jun; 92(6):757-9. PubMed ID: 10410814 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis of multiple sclerosis. Schwankhaus JD Am Fam Physician; 1984 Jan; 29(1):231-6. PubMed ID: 6695648 [TBL] [Abstract][Full Text] [Related]
18. Immediate cutaneous hypersensitivity response to phytomenadione induced by vitamin K in skin diagnostic procedure. Giménez-Arnau AM; Toll A; Pujol RM Contact Dermatitis; 2005 May; 52(5):284-5. PubMed ID: 15899004 [No Abstract] [Full Text] [Related]